ISMP Canada Launches the first Canadian High-Alert Medication List

“The number of Canadian patients harmed by medications each year is unacceptable. We collaborated with our partners across Canada to identify a list of medications that are more likely to result in harm when an error occurs. Healthcare organizations can use the list to take action to reduce this risk,” said Carolyn Hoffman, CEO of ISMP Canada.

Read more